Johnson & Johnson To Begin Human Trial For COVID-19 Vaccine In September

Johnson and Johnson, the international pharmaceutics and medical supplies company said that its goal is to provide more than 1 billion doses of a COVID-19 vaccine. Human trials for the vaccine would begin by September at the latest and be available for early use authorization in early 2021. As of now, there is no vaccine to prevent coronavirus, and there is no approved treatment for the condition.